Taiwan FDA registration 1f45f75f2d0e727eb3f74015a103ebe0
Longteng tumor embryonic protein in vitro reagent card
TW: 龍騰腫瘤胚蛋白體外試劑卡
Taiwan·Risk Class 2·The first factory of Longteng Biotechnology Co., Ltd·Registered Dec 07, 2006 – Dec 07, 2016CancelledRegistration details
- Analysis ID
- 1f45f75f2d0e727eb3f74015a103ebe0
- Customs Code
- DHY00500228801
Company information
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- The first factory of Longteng Biotechnology Co., Ltd
Product details
- Intended Use
- Qualitative detection of tumor embryo protein (CEA) in human serum.
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.6010 腫瘤相關抗原免疫試驗系統
- Import Information
- Domestic
Dates and status
- Registration Date
- Dec 07, 2006
- Expiry Date
- Dec 07, 2016
- Cancellation Date
- Dec 13, 2019
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for Longteng tumor embryonic protein in vitro reagent card in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 1f45f75f2d0e727eb3f74015a103ebe0 and manufactured by The first factory of Longteng Biotechnology Co., Ltd. The authorized representative in Taiwan is The first factory of Longteng Biotechnology Co., Ltd.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices